New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
10:13 EDTZ, XLNX, VOLVY, UEIC, THRX, TISI, TMUS, SRLP, STM, ZQK, MCHP, ESRX, IFNNY, BIG, BNPQYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BNP Paribas (BNPQY) downgraded to Neutral from Conviction Buy at Goldman... Big Lots (BIG) downgraded to Equalweight from Overweight at Barclays... Express Scripts (ESRX) downgraded at Cowen... Infineon (IFNNY) downgraded to Neutral from Buy at Citigroup... Microchip Technology (MCHP) downgraded to Neutral from Buy at Goldman... Quiksilver (ZQK) downgraded at B. Riley... STMicroelectronics (STM) downgraded to Sell from Neutral at Citigroup... Sprague Resources (SRLP) downgraded to Neutral from Overweight at JPMorgan... T-Mobile (TMUS) downgraded to Neutral from Outperform at Macquarie... Team (TISI) downgraded to Hold from Buy at BB&T... Theravance (THRX) downgraded at RW Baird... Universal Electronics (UEIC) downgraded to Neutral from Buy at B. Riley... Volvo (VOLVY) downgraded to Sell from Neutral at Goldman... Xilinx (XLNX) downgraded to Neutral from Buy at Goldman... Zillow (Z) downgraded at Pacific Crest.
News For BNPQY;BIG;IFNNY;ESRX;MCHP;ZQK;STM;SRLP;TMUS;TISI;THRX;UEIC;VOLVY;XLNX;Z From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 24, 2014
05:18 EDTVOLVYVolvo reports Q3 EPS SEK 0.74 vs. SEK 0.68 last year
Reports Q3 revenue SEK 67.2B vs. SEK 64.9B last year. Volvo CEO Olof Persson stated, “The activities within the Strategic Program 2013-2015 are being implemented as planned. We have identified additional opportunities to reduce our structural cost level and we are therefore increasing the scope of our strategic program with the following activities: Implement further cost-reduction activities in Volvo CE, reorganize Group Trucks Sales in order to increase efficiency and reduce costs and review what is core and non-core in in our IT operations.”
October 23, 2014
10:01 EDTIFNNYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:48 EDTTMUSDeutsche Telekom looking for potential buyer for T-Mobile, Manager Magazin says
Deutsche Telekom (DTEGY) is looking for a potential buyer for T-Mobile (TMUS) that will be able to overcome U.S. regulator anti-trust concerns, according to Germany's Manager Magazin. Reference Link
08:17 EDTTMUSMavenir Systems selected by T-Mobile Netherlands
Subscribe for More Information
08:14 EDTMCHPMicrochip announces strategic partnership with Xymox Technologies
Subscribe for More Information
07:25 EDTTMUSCitigroup, others careful of Ergen amid possible T-Mobile offer, Bloomberg says
Subscribe for More Information
05:58 EDTXLNXStocks with implied volatility below IV index mean; XLNX JNJ
Subscribe for More Information
05:45 EDTIFNNYInfineon upgraded to Overweight from Neutral at HSBC
Subscribe for More Information
October 22, 2014
14:43 EDTTHRXTheravance drops after partner announces restructuring, posts abstracts
Shares of Theravance, (THRX) a biopharmaceutical company that has economic ties to GlaxoSmithKline (GSK), are lower in afternoon trading after Glaxo reported restructuring plans. Additionally, Theravance disclosed last night that GSK is scheduled to present data from Phase 3 studies at an upcoming medical conference. CHEST 2014 in Austin, Texas, to be held from October 25-30. WHAT'S NEW: Earlier today, GlaxoSmithKline announced it intends to refocus its global pharmaceuticals business and cost base following the divestment of its oncology products and the changed dynamics now faced in the U.S. respiratory market. Theravance has strategic alliances with GlaxoSmithKline in respiratory products. Also, Theravance disclosed last night that Glaxo is scheduled to present data from Phase 3 studies at CHEST 2014, which is being held from October 25-30. Umeclidinium/Vilanterol, a once-daily combination treatment comprising two bronchodilators in Theravance's ELLIPTA inhaler, and Fluticasone Furoate/Vilanterol, a once-daily combination of a LABA and inhaled corticosteroid, have been developed under a collaboration pact between Glaxo and Theravance. Abstracts of the planned oral presentations can be found in the CHEST Journal, Theravance noted in its filing. PRICE ACTION: In afternoon trading, shares of Theravance fell 10.25% to $16.73.
11:14 EDTTHRXHigh option volume stocks
Subscribe for More Information
10:03 EDTXLNXThe Linley Group to hold a conference
Subscribe for More Information
09:23 EDTESRXExpress Scripts getting more aggressive on pricing, says Cleveland Research
Subscribe for More Information
06:42 EDTVOLVYVolvo management to meet with Piper Jaffray
Meetings to be held in San Francisco on October 28 and in Los Angeles on October 29 hosted by Piper Jaffray.
06:14 EDTXLNXStocks with implied volatility below IV index mean; XLNX NFLX
Stocks with implied volatility below IV index mean; Xilinx (XLNX) 24, Netflix (NFLX) 35 according to iVolatility.
October 21, 2014
13:43 EDTTMUST-Mobile and FTC in talks to settle phone charge suit, Bloomberg says
Subscribe for More Information
October 20, 2014
14:29 EDTMCHPEarnings Preview: Texas Instruments down 9% over last three months
Semiconductor maker Texas Instruments (TXN) is expected to report third quarter earnings after the close on Monday, October 20, with a conference call scheduled for 5:30 pm ET. EXPECTATIONS: Analysts are looking for earnings per share of 71c on revenue of $3.46B. The consensus range is 66c-74c for EPS on revenue of $3.44B-$3.5B, according to First Call. Along with its last earnings report, Texas Instruments guided to Q3 EPS of 66c-76c on revenue of $3.31B-$3.59B. LAST QUARTER: On July 21, Texas Instruments reported second quarter EPS of 62c, which was higher than analysts' consensus of 59c. The company's revenue of $3.29B exceeded analysts' expectation of $3.27B. Texas Instruments noted that the restructuring changes which occurred in Q2 are positioned to be nil in Q3 and noted that it anticipated utilization in Q3 to remain consistent with Q2 levels. NEWS: On September 18, Texas Instruments increased its quarterly dividend by 13% to 34c. WHAT'S NOTABLE: After the close on October 9, Microchip (MCHP), which develops microcontroller and analog semiconductors, said that it had experienced a number of negative trends during the quarter, including a weaker than usual September, weakness in China, and significant inventory builds at its distributor customers. Microchip President and CEO Steve Sanghi claimed his company often sees the turn of the semiconductor industry ahead of others, noting that it reports sales from distribution on a sell-through basis and that it does business with over 80,000 customers. Sanghi stated, "We believe that another industry correction has begun and that this correction will be seen more broadly across the industry in the near future." STREET RESEARCH: Analysts were fairly quiet on Texas Instruments during the quarter. The day after the company issued its Q2 earnings report, Sterne Agee believed that Texas Instruments' commentary on 4G telecom, auto and industrial strength should be positive for Spansion (CODE). RBC Capital noted on the same day that Texas Instruments had "strong" Q2 results, particularly in its execution, while its operating margin leverage was "impressive. The firm maintained a $57 price target and Outperform rating on the stock. On July 24, Tigress Financial upgraded Texas Instruments to Neutral from Underperform. PRICE ACTION: Over the last three months, Texas Instruments' shares are down about 9%. Since October 10, the day after Microchip's warning on the industry correction it believes has begun, Texas Instruments shares are down over 3%. In afternoon trading before tonight's report, Texas Instruments was up 1.7% to $44.41.
13:53 EDTTMUSEarnings Preview: Verizon sentiment mixed ahead of Q3 report
Subscribe for More Information
12:36 EDTXLNXOptions with decreasing implied volatility
Subscribe for More Information
08:07 EDTTMUST-Mobile coverage resumed with an Overweight at Morgan Stanley
Subscribe for More Information
07:24 EDTZZillow November weekly volatility elevated into Q3 and outlook
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use